The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois

The University of Chicago Medicine Comprehensive Cancer Center is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Chicago Medicine Comprehensive Cancer Center has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Arthritis, Arthropathy, HER2-positive Breast Cancer.

Sponsors: University of Chicago, QuantumLeap Healthcare Collaborative, Jounce Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Chicago Medicine Comprehensive Cancer Center?

The University of Chicago Medicine Comprehensive Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Chicago Medicine Comprehensive Cancer Center conducted?

The University of Chicago Medicine Comprehensive Cancer Center has 5 clinical trials on record, with 4 currently active. Their work covers Arthritis, Arthropathy, HER2-positive Breast Cancer.

Is The University of Chicago Medicine Comprehensive Cancer Center accredited by Crixeo Health?

Yes — The University of Chicago Medicine Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Chicago Medicine Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.